PubMed HealthSearch

PubMed · 3971956

Solvent interactions with test compounds and recommendations for testing to avoid artifacts.

Abstract

Reports in the literature describing artifactual results owing to interactions of test materials with solvents are becoming more frequent. The present study was initiated to examine possible interactions of 1,1,3-trichloro-, 1,1,3,3-tetrachloro-, pentachloro- and hexachloroacetones with different solvents, since certain solvent effects with the last compound have been shown previously. Quantitative differences in levels of mutagenic potency were found for tri-, tetra-, and pentachloroacetone, dissolved in acetone or dimethyl sulfoxide (DMSO). On the other hand, hexachloroacetone without solvent was mutagenic, and this activity was enhanced when it was dissolved in DMSO; in acetone it was not mutagenic. A time-dependent reaction of hexachloroacetone with DMSO was the only test material-solvent interaction found in this study. The results show clearly that DMSO is not an appropriate solvent for hexachloroacetone. On the basis of these and previous results, we recommend consideration of the following strategy to help prevent reporting of artifactual results owing to interaction with solvents: Results from initial screening experiments should be confirmed in repeat experiments using a different solvent; and a different solvent should be used in confirming the findings of other investigators. Differences in results would indicate a need for further study.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

E R Nestmann, G R Douglas, D J Kowbel, T R Harrington. 1985. Solvent interactions with test compounds and recommendations for testing to avoid artifacts.. https://doi.org/10.1002/em.2860070205

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Breath acetone in congestive heart failure.

To summarize, CHF predisposes to postabsorptive ketosis in relation to the severity of venous congestion. A simple and fully noninvasive measurement of breath acetone may add to the diagnostic assessment of patients with CHF.

Acetone

Ketone potentiation of haloalkane-induced hepato- and nephrotoxicity. II. Implication of monooxygenases.

Previous results in Sprague-Dawley rats indicate that acetone (A), methyl ethyl ketone (MEK), and methyl isobutyl ketone (MiBK) pretreatment (3 d, po) at dosages of 6.8 and 13.6 mmol/kg potentiate CCl4 hepatotoxicity and CHCl3 nephrotoxicity, respectively. The potentiation potency profile observed was MiBK > A > MEK for liver and A > MEK > or = MiBK for kidney toxicity (Raymond & Plaa, 1995). In the present study, hepatic and renal microsomes from A-, MEK-, and MiBK-pretreated rats (6.8 or 13.6 mmol/kg) were examined for cytochrome P-450 content, substrate-specific monooxygenase activity (aminopyrine and benzphetamine N-demethylase, aniline hydroxylase) and in vitro covalent binding of 14CHCl3 and 14CCl4. Of the three ketones, only MiBK significantly increased P-450 content of liver and renal cortical microsomes. Similarly, 14CCl4 covalent binding under aerobic and anaerobic conditions was significantly increased by MiBK pretreatment only. 14CHCl3 covalent binding by renal cortical microsomes was significantly increased only under aerobic conditions by MiBK pretreatment. MiBK (13.6 mmol/kg) increased (threefold) aminopyrine N-demethylation in both liver and kidney, but only benzphetamine N-demethylation (two-fold, at 6.8 and 13.6 mmol/kg) in liver; A and MEK had no effect on either monooxygenase. All ketones at dosages of 6.8 and 13.6 mmol/kg increased aniline hydroxylation in liver (two-fold) and kidney (fivefold). Comparable profiles for P-450 induction, haloalkane covalent binding, and aminopyrine or benzphetamine N-demethylase activity were observed in liver and kidney microsomes. This profile was consistent with the ketone potentiation potency ranking profile observed in vivo for liver but not kidney injury. These findings affirm the importance of ketone-enhanced bioactivation for potentiation of CCl4 hepatotoxicity but suggest an alternative mechanism for CHCl3 nephrotoxicity.

Acetone

Purification and properties of 6-methylsalicylic acid synthase from Penicillium patulum.

6-Methylsalicylic acid synthase has been isolated in homogeneous form from Penicillium patulum grown in liquid culture from a spore inoculum. The enzyme is highly susceptible to proteolytic degradation in vivo and in vitro, but may be stabilized during purification by incorporating proteinase inhibitors in the buffers. The enzyme exists as a homotetramer of M(r) 750,000, with a subunit M(r) of 180,000. 6-Methylsalicyclic acid synthase also accepts acetoacetyl-CoA as an alternative starter molecule to acetyl-CoA. The enzyme also catalyses the formation of small amounts of triacetic acid lactone as an oligatory by-product of the reaction. In the absence of NADPH, triacetic acid lactone is the exclusive enzymic product, being formed at 10% of the rate of 6-methylsalicylic acid. The enzyme is inactivated by 1,3-dibromopropan-2-one, leading to the formation of cross-linked dimers similar to that observed with type I fatty acid synthases. Acetyl-CoA protects the enzyme against the inactivation and inhibits dimer formation. An adaptation of the purification method for 6-methylsalicylic acid synthase may be used for the isolation of fatty acid sythase from Penicillium patulum.

Acetone